27 studies found for:
" May 29, 2007":" June 29, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Display Options
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients
|
||||
| 2 | Completed |
Growth Hormone in the Treatment of HIV-Associated Wasting
|
||||
| 3 | Completed |
Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
|
||||
| 4 |
Completed
Has Results |
Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
|
||||
| 5 | Completed |
Microbicides Acceptability Among Sexually Active Young Women
|
||||
| 6 | Unknown † |
Effects of HIV and Hepatitis C Virus on the Brain
|
||||
| 7 | Completed |
Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
|
||||
| 8 | Unknown † |
HIV Prevention in Haitian American Adolescents
|
||||
| 9 | Suspended |
Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
|
||||
| 10 | Completed |
Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
|
||||
| 11 | Completed |
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
|
||||
| 12 | Completed |
ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency
|
||||
| 13 | Completed |
Effects of Creatine and Resistance Exercise Training in People With HIV Infection
|
||||
| 14 | Unknown † |
Engaging Care for HIV-Infected Adolescent Females.
|
||||
| 15 | Unknown † |
A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication
|
||||
| 16 | Completed |
Project HERMITAGE: HIV Prevention in Hospitalized Russian Drinkers
|
||||
| 17 | Completed |
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
|
||||
| 18 | Completed |
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
|
||||
| 19 | Unknown † |
Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
|
||||
| 20 | Withdrawn |
Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
|
† Indicates status has not been verified in more than two years
